Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 34, 1808-1812, August 1, 1974]
© 1974 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cauchi, M. N.
Right arrow Articles by Williams, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cauchi, M. N.
Right arrow Articles by Williams, J. F.

Hepatocellular Localization of Fetal Antigens during Induction of Rat Liver Tumors by 3'-Methyl-4-dimethylaminoazobenzene1

M. N. Cauchi2, J. B. W. Halley, M. G. Irving and J. F. Williams

Department of Pathology and Immunology, Monash University Medical School, Melbourne, Victoria [M. N. C.]; Institute of Radiotherapy, The Prince of Wales Hospital, Avoca Street, Randwick, New South Wales [J. B. W. H., M. G. I.]; and School of Biochemistry, University of New South Wales, Kensington, New South Wales [J. F. W.], Australia

Hepatic tumors regularly occur in rats after the ingestion of 3'-methyl-4-dimethylaminoazobenzene for 120 days. The appearance of embryonic-type antigens prior to obvious neoplastic transformation was studied with the use of antisera against fetal rat serum (anti-{alpha}-fetoprotein) and fetal liver antigen.

Within 20 days of administration of carcinogen, {alpha}-fetoprotein was detected in the circulation by means of gel diffusion. By 40 days, both {alpha}-fetoprotein and fetal liver antigen could be localized by indirect immunofluorescent techniques in the livers of treated animals but not in control rats. The staining was confined to small patches which increased in size and became confluent with frankly neoplastic lesions.

There was no evidence of antibody production to fetal antigens, but autoantibodies reacting with cell nuclei and with liver cell cytoplasm were detected by immunofluorescent techniques.

1 This work was supported by grants from the Anticancer Council of Victoria and the Australian Research Grants Committee.

2 To whom reprint requests should be addressed, The Department of Pathology and Immunology, Monash Medical School, Prahran, Victoria, Australia 3181.

Received 1/30/74. Accepted 4/10/74.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1974 by the American Association for Cancer Research.